Concepedia

M. Bayssas

MB

Statistics

Publications

20

Citations

1.8K

H-Index

16

Active since

1978

Affiliations

Debiopharm (Switzerland)(Current)

University of Milano-Bicocca

Hôpital Paul-Brousse

Anton Proksch Institut

Antwerp University Hospital

M. Bayssas is an author at Debiopharm (Switzerland) specializing in chemotherapy, pharmacology, and medicine.

Publications per year

1978–2004

20

Publications

20

Clinical pharmacokinetics of oxaliplatin: a critical review.

Martin A. Graham, G. Lockwood, Dennis Greenslade et al. · PubMed · 2000 · 461 citations

, , +15

Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat

Guido Cavaletti, G Tredici, M G Petruccioli et al. · European Journal of Cancer · 2001 · 286 citations

, , +7

Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer.

B Chevallier, P. Fumoleau, Pierre Kerbrat et al. · Journal of Clinical Oncology · 1995 · 223 citations

, , +16

A phase II trial with Docetaxel (Taxotere™) in second line treatment with chemotherapy for advanced breast cancer

W.W. ten Bokkel Huinink, A. Prové, Martine Piccart et al. · Annals of Oncology · 1994 · 138 citations

, , +11

Phase I Trial of Taxotere: Five-Day Schedule

Richard Pazdur, Robert A. Newman, Beth Newman et al. · JNCI Journal of the National Cancer Institute · 1992 · 134 citations

, , +16

1–5 of 20